Creative Biolabs Bispecific Antibody Blog

Menu

Skip to content
  • Bispecific Antibody Research
  • Bispecific Antibody Clinic
  • News

Monthly Archives: November 2022

18Nov/22

Bispecific Antibody Research Update: Epcoritamab Receives FDA Priority Review

November 18, 2022Bispecific Antibody ResearchBispecific Antibody, CD3×CD20, Epcoritamabbiobsab

Bispecific antibodies, with two binding sites directed at two different antigens or two different epitopes on the same antigen, have shown some superiority in clinical therapeutic effects when compared with monoclonal antibodies,Read More…

Categories

  • Bispecific Antibody Clinic
  • Bispecific Antibody Research
  • BSAB
  • Cancer Immunotherapy
  • Events
  • News

Recent Posts

  • ISB 1442: A Novel Bispecific Antibody for Targeting CD38+ Hematologic Malignancies
  • Advancing HIV-1 Therapy: Bispecific Antibodies to Enhance Latent Reservoir Clearance
  • Unveiling a New Mechanism: How CD47 Shields Cancer Cells from Immune Clearance
  • New Cancer Therapy Target May Disrupt Shared Resources Among Tumor Cells
  • Natural Products Targeting Tumor Angiogenesis

Archives

  • March 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • February 2022
  • March 2021
  • December 2020
  • October 2020
  • August 2020
  • June 2019
  • April 2019
  • March 2019
  • February 2019
  • December 2018
  • November 2018
  • October 2018

Contact Us

USA - UK
Copyright © Creative Biolabs Bispecific Antibody Blog
Powered by WordPress , Theme i-max by TemplatesNext.
MENU
  • Bispecific Antibody Research
  • Bispecific Antibody Clinic
  • News